Xencor
XNCR
$19.98
Share price
3.90%
Change (1 day)
-24.46%
Change (1 year)
Categories
P/S ratio for Xencor (XNCR)
P/S ratio as of April 2024 (TTM): 7.33
According to Xencor's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.32791. At the end of 2023 the company had a P/S ratio of 7.68.
P/S ratio history for Xencor from 2013 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 7.68 | -19.03% |
| 2022 | 9.48 | 11.17% |
| 2021 | 8.53 | -58.26% |
| 2020 | 20.4 | 63.61% |
| 2019 | 12.5 | -75.08% |
| 2018 | 50.1 | 31.17% |
| 2017 | 38.2 | 173.76% |
| 2016 | 14.0 | -34.64% |
| 2015 | 21.4 | -59.68% |
| 2014 | 53.0 | 87.99% |
| 2013 | 28.2 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.79 | -48.34% | 🇺🇸 USA |
 AbbVie ABBV | 5.20 | -28.99% | 🇺🇸 USA |
 Amgen AMGN | 5.14 | -29.90% | 🇺🇸 USA |
 Merck MRK | 5.53 | -24.56% | 🇺🇸 USA |
 Seagen
SGEN | 18.8 | 156.01% | 🇺🇸 USA |
 MacroGenics MGNX | 16.0 | 118.19% | 🇺🇸 USA |